H. Bridgeman

发表

Amphiregulin-producing γδ T cells are vital for safeguarding oral barrier immune homeostasis

J. Grainger, D. Bowdish, J. Konkel, 2018, Proceedings of the National Academy of Sciences.

Highly prevalent colorectal cancer-infiltrating LAP+ Foxp3− T cells exhibit more potent immunosuppressive activity than Foxp3+ regulatory T cells

K. Ladell, R. Hargest, A. Christian, 2013, Mucosal Immunology.

T-cell trafficking facilitated by high endothelial venules is required for tumor control after regulatory T-cell depletion.

K. Ladell, A. Godkin, J. Hindley, 2012, Cancer research.

Tissue-resident macrophages in the intestine are long lived and defined by Tim-4 and CD4 expression

Ping Wang, J. Grainger, Samira Tamoutounour, 2018, The Journal of experimental medicine.

On-going Mechanical Damage from Mastication Drives Homeostatic Th17 Cell Responses at the Oral Barrier

Y. Belkaid, G. Trinchieri, Simon A. Jones, 2017, Immunity.

On-going Mechanical Dam age from Mastication Drives Homeostatic Th 17 Cell Responses at the Oral Barrier Highlights

Y. Belkaid, G. Trinchieri, B. Hong, 2017 .

Progression of carcinogen‐induced fibrosarcomas is associated with the accumulation of naïve CD4+ T cells via blood vessels and lymphatics

Katherine K. Matthews, K. Ladell, D. Jackson, 2013, International journal of cancer.

Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer

R. Hills, A. Godkin, A. Gallimore, 2017, Clinical Cancer Research.

Effect of Modified Vaccinia Ankara–5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer

R. Hills, A. Godkin, A. Gallimore, 2017, JAMA oncology.

MVA-5T4 immunotherapy (TroVax) and low-dose cyclophosphamide for advanced colorectal cancer (TaCTiCC): an open-label, randomized phase 1/2 clinical trial

Adams, R. Hills, Daniel, 2017 .

MVA-5T4 immunotherapy (TroVax) and low-dose cyclophosphamide for advanced colorectal cancer (TaCTiCC): an open-label, randomized phase 1/2 clinical trial

R. Hills, A. Godkin, A. Gallimore, 2017 .

Effect ofModified Vaccinia Ankara – 5 T 4 and Low-Dose Cyclophosphamide on Antitumor Immunity inMetastatic Colorectal Cancer A Randomized Clinical Trial

R. Hills, A. Godkin, A. Gallimore, 2017 .

Escalating Regulation of 5T4-Specific IFN-γ+ CD4+ T Cells Distinguishes Colorectal Cancer Patients from Healthy Controls and Provides a Target for In Vivo Therapy

R. Hargest, A. Christian, A. Godkin, 2013, Cancer Immunology Research.

Avidity of influenza-specific memory CD8+ T-cell populations decays over time compromising antiviral immunity

K. Ladell, L. Wooldridge, H. A. van den Berg, 2012, European journal of immunology.

Hematopoietic stem and progenitor cells are present in healthy gingiva tissue

J. Grainger, J. Konkel, S. Krishnan, 2021, The Journal of experimental medicine.

Highly prevalent colorectal cancer-infiltrating LAP

K. Ladell, R. Hargest, A. Godkin, 2023 .

Eliminating roles for T-bet and IL-2 but revealing superior activation and proliferation as mechanisms underpinning dominance of regulatory T cells in tumors

K. Ladell, S. Anderton, R. O’Connor, 2015, Oncotarget.

CD163 and Tim-4 identify resident intestinal macrophages across sub-tissular regions that are spatially regulated by TGF-β

M. Guilliams, J. Grainger, J. Konkel, 2023, bioRxiv.